Diagnostic Histopathology
Volume 14, Issue 10 , Pages 509-518 , October 2008

Current issues in pulmonary adenocarcinoma

References 

  1. Fu JB, Ying Kau T, Severson RK, et al. Lung cancer in women: analysis of the national surveillance, epidemiology and end results database. Chest. 2005;127:768–777
  2. Strauss GM, Jemal A, McKenna MB, et al. The epidemic of smoking-related adenocarcinoma of the lung: the role of the tobacco industry and filtered and low-tar cigarettes. J Thorac Oncol. 2007;2(Suppl. 4):S305
  3. Noguchi M, Morokawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995;75:2844–2852
  4. Colby TV, Noguchi M, Henschke C, et al. Adenocarcinoma. In:  Travis WD,  Brambilla E,  Muller-Hermelink HK editor. World Health Organization classification of tumours. pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004;p. 35–44
  5. Ma Y, Seneviratne CK, Koss M. Idiopathic pulmonary fibrosis and malignancy. Curr Opin Pulm Med. 2001;7:278–282
  6. Shimosato Y, Kodama T, Kameya T. Morphogenesis of peripheral type adenocarcinoma of the lung. In:  Shimosato Y,  Melamed MR,  Nettesheim P editor. Morphogenesis of lung cancer. vol 1:Boca Raton, FL: CRC Press; 1982;p. 65–90
  7. Kerr KM, Fraire AE, Pugatch B, et al. Atypical adenomatous hyperplasia. In:  Travis WD,  Brambilla E,  Muller-Hermelink HK editor. World Health Organisation classification of tumours. pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004;p. 73–75
  8. Yokose T, Doi M, Tanno K, Yamazaki K, Ochiai A. Atypical adenomatous hyperplasia of the lung in autopsy cases. Lung Cancer. 2001;33:155–161
  9. Sterner DJ, Masuko M, Roggli VL, et al. Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: a study of 100 cases. Mod Pathol. 1997;10:469–473
  10. Weng S-Y, Tsuchiya E, Kasuga T, et al. Incidence of atypical bronchioloalveolar cell hyperplasia of the lung: relation to histological subtypes of lung cancer. Virchows Archiv A Pathol Anat Histopathol. 1992;420:463–471
  11. Koga T, Hashimoto S, Sugio K, et al. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia. Am J Clin Pathol. 2002;117:464–470
  12. Nakahara R, Yokose T, Nagai K, et al. Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia. Thorax. 2001;56:302–305
  13. Miller RR. Bronchioloalveolar cell adenomas. Am J Surg Pathol. 1990;14:904–912
  14. Chapman AD, Kerr KM. The association between atypical adenomatous hyperplasia and primary lung cancer. Br J Cancer. 2000;83:632–636
  15. Kerr KM. Morphology and genetics of preinvasive pulmonary disease. Curr Diagn Pathol. 2004;10:259–268
  16. Miller RR, Nelems B, Evans KG, et al. Glandular neoplasia of the lung. A proposed analogy to colonic tumours. Cancer. 1988;61:1009–1014
  17. Kerr KM, Noguchi M. Pathology of screen-detected lesions. In:  Hirsch FR,  Bunn PA,  Kato H,  Mulshine JL editor. IASLC Textbook on Prevention and early detection of lung cancer. London: Martin Dunitz; 2005;p. 245–267
  18. Kerr KM, Devereux G, Chapman AD, et al. Is survival after surgical resection of lung cancer influenced by the presence of atypical adenomatous hyperplasia (AAH)?. J Thorac Oncol. 2007;2(Suppl. 4):S401–S402
  19. Yousem SA, Beasley MB. Bronchioloalveolar carcinoma. A review of current concepts and evolving issues. Arch Pathol Lab Med. 2007;131:1027–1032
  20. Yokose T, Suzuki K, Nagai K, et al. Favourable and unfavourable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Lung Cancer. 2000;29:179–188
  21. Suzuki K, Yokose T, Yoshida J, et al. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann Thorac Surg. 2000;69:893–897
  22. Maeshima AM, Niki T, Maeshima A, et al. Modified scar grade. A prognostic indicator in small peripheral lung adenocarcinoma. Cancer. 2002;95:2546–2554
  23. Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinoma of the lung. Histopathological minimal invasion and prognosis. Am J Surg Pathol. 2004;28:198–206
  24. Minami Y, Matsuno Y, Iijima T, et al. Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer. 2005;48:339–348
  25. Okudera K, Kamata Y, Takanashi S, et al. Small adenocarcinoma of the lung: prognostic significance of central fibrosis chiefly because of its association with angiogenesis and lymphangiogenesis. Pathol Int. 2006;56:494–502
  26. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and CT imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005;23:3279–3287
  27. Kerr KM, Fyfe MN, Nicolson MC, et al. Influence of tumour patterns in mixed-type adenocarcinoma on post-operative survival. J Thorac Oncol. 2007;2(Suppl. 4):S801–S802
  28. Travis WD, Garg K, Franklin WA, et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 WHO pathologic criteria. J Thorac Oncol. 2006;19:s13–s19
  29. Sakao Y, Miyamoto H, Sakuraba M, et al. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components. Ann Thorac Surg. 2007;83:209–214
  30. Castro CY, Coffey DM, Medeiros LJ, et al. Prognostic significance of percentage of bronchioloalveoler pattern in adenocarcinomas of the lung. Ann Diagn Pathol. 2001;5:274–284
  31. Lin D-M, Ma Y, Zheng S, et al. Prognostic value of bronchioloalveolar carcinoma component in lung adenocarcinoma. Histol Histopathol. 2006;21:627–632
  32. Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histolgic features predict outcome for bronchioloalveolar carcinoma. Ann Thorac Surg. 2002;74:1640–1647
  33. Kerr KM, Fyfe N, Chapman AD, et al. Cell cycle marker MCM2 in peripheral lung adenocarcinoma and its precursors. Lung Cancer. 2003;41:S15
  34. Kerr KM, MacKenzie SJ, Ramasami S, et al. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma. J Pathol. 2004;203:638–644
  35. Kitamura H, Kameda Y, Nakamura N, et al. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol. 1996;20:553–562
  36. Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2:706–714
  37. Silver SA, Askin FB. True papillary carcinoma of the lung. A distinct clinicopathologic entity. Am J Surg Pathol. 1997;21:43–51
  38. Aida S, Shimazaki H, Sato K, et al. Prognostic analysis of pulmonary adenocarcinoma subclassification with special consideration of papillary and bronchioloalveolar types. Histopathology. 2004;45:468–476
  39. Jian Z, Tomizawa Y, Yanagitani N, et al. Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes. Pathol Int. 2005;55:619–625
  40. Moran CA. Pulmonary adenocarcinoma. The expanding spectrum of histologic variants. Arch Pathol Lab Med. 2006;130:958–962
  41. Amin MB, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma. A distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 2002;26:358–364
  42. Miyoshi T, Satoh Y, Okumura S, et al. Early stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol. 2003;27:101–109
  43. Roh MS, Lee JI, Choi PJ, et al. Relationship between micropapillary component and micrometastasis in the regional lymph nodes of patients with stage 1 lung adenocarcinoma. Histopathology. 2004;45:580–586
  44. Makimoto Y, Nabeshima K, Iwasaki H, et al. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (≤20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi’s type C tumours). Histopathology. 2005;46:677–684
  45. Tsutsumida H, Nomoto M, Goto M, et al. A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis. Mod Pathol. 2007;20:638–647
  46. Kawakami T, Nabeshima K, Makimoto Y, et al. Micropapillary pattern and grade of stromal invasion in pT1 adenocarcinoma of the lung: usefulness as prognostic factors. Mod Pathol. 2007;20:514–521
  47. Riquet M, Foucault C, Berna P, et al. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. Ann Thorac Surg. 2006;81:1988–1995
  48. Gao ZH, Urbanski SJ. The spectrum of pulmonary mucinous cystic neoplasia: a clinicopathologic and immunohistochemical study of ten cases and review of the literature. Am J Clin Pathol. 2005;124:62–70
  49. Rossi G, Murer B, Cavazza A, et al. Primary mucinous (so- called colloid) carcinomas of the lung: a clinicopathological and immunohistochemical study with special reference to CDX2 homeobox gene and MUC2 expression. Am J Surg Pathol. 2004;28:442–452
  50. Yatabe Y, Koga T, Mitsudomi T, Takahashi T. CK20 expression, CDX2 expression, K-ras mutation and goblet cell morphology in a subset of lung adenocarcinomas. J Pathol. 2004;203:645–652
  51. Mazziotta RM, Borczuk AC, Powell CA, Mansukhani M. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall. Appl Immunohistochem Mol Morphol. 2005;13:55–60
  52. Yousem SA. Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study. Mod Pathol. 2005;18:816–821
  53. Marchetti A, Buttitta F, Pellegrini S, et al. Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype. J Pathol. 1996;179:254–259
  54. Corrin B. Secondary tumours of the lungs. In:  Corrin B editors. Pathology of the lung. London: Churchill Livingstone; 2000;p. 573–584
  55. Dail D, Cagle PT, Marchevsky AM, et al. Metastases to the Lung. In:  Travis WD,  Brambilla E,  Muller-Hermelink HK editor. World Health Organization classification of tumours. pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004;p. 122–124
  56. Pao W, Miller VA. Epidermal growth factor receptor mutations, small molecule kinase inhibitors and non-small-cell carcinoma: current knowledge and future directions. J Clin Oncol. 2005;23:2556–2568
  57. Sequist LV, Bell DW, Lynch TJ, et al. Molecular predictors of response to epidermal growth factor receptor antagonists on non- small cell lung cancer. J Clin Oncol. 2007;25:587–595

PII: S1756-2317(08)00121-7

doi: 10.1016/j.mpdhp.2008.07.010

Diagnostic Histopathology
Volume 14, Issue 10 , Pages 509-518 , October 2008

Article Tools

* Image Usage & Resolution